Concepedia

Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease

E. H. Heinonen, M. Savijärvi, Miika Kotila, A. Hajba, Mika Scheinin

Journal of Neural Transmission - Parkinsons Disease and Dementia Section · 1993 · 19 citations · 38 references

DOI

Concepts

References

38

Clinical diagnosis of Alzheimer's disease

Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 27.8K citations · Full text

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

New England Journal of Medicine · 1989 · 916 citations

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

James W. Tetrud, J. William Langston · Science · 1989 · 645 citations

, , +15

Is the mesocortical dopaminergic system involved in Parkinson disease?

France Javoy‐Agid, Yves Agid · Neurology · 1980 · 409 citations

Dopamine is a monoamine oxidase B substrate in man

Vivette Glover, M. Sandler, F. Owen et al. · Nature · 1977 · 328 citations

, , +4